UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MYC regulates the antitumor immune response through CD47 and PD-L1

Science (American Association for the Advancement of Science), 2016-04, Vol.352 (6282), p.227-231

2016

Volltextzugriff (PDF)

Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma

Journal for immunotherapy of cancer, 2018-11, Vol.6 (1), p.125-125, Article 125

2018

Volltextzugriff (PDF)

MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity

eLife, 2020-01, Vol.9

2020

Volltextzugriff (PDF)

Hsp27 as a therapeutic target in cancers

Current drug targets, 2014-04, Vol.15 (4), p.423-431

2014

Volltextzugriff (PDF)

Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments

Cancers, 2023-10, Vol.15 (20), p.5047

2023

Volltextzugriff (PDF)

Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs

Communications biology, 2024-04, Vol.7 (1), p.489-489, Article 489

2024

Volltextzugriff (PDF)

Synthesis, Crystal Structure and Anti-Leukemic Activity of (E)-Pyrrolo[1,2-a]quinoxalin-4-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one

MolBank, 2023-09, Vol.2023 (3), p.M1691

2023

Volltextzugriff (PDF)

The MYC oncogene is a global regulator of the immune response

Blood, 2018-05, Vol.131 (18), p.2007-2015

2018

Volltextzugriff (PDF)

MYC: Master Regulator of Immune Privilege

Trends in immunology, 2017-04, Vol.38 (4), p.298-305

2017

Volltextzugriff (PDF)

TCTP as therapeutic target in cancers

Cancer treatment reviews, 2014-07, Vol.40 (6), p.760-769

2014

Volltextzugriff (PDF)

Salmonella Typhimurium utilizes a T6SS-mediated antibacterial weapon to establish in the host gut

Proceedings of the National Academy of Sciences - PNAS, 2016-08, Vol.113 (34), p.E5044-E5051

2016

Volltextzugriff (PDF)

Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer

Journal of controlled release, 2017-07, Vol.258, p.1-9

2017

Volltextzugriff (PDF)

NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myeloma

Blood, 2024-09, Vol.144 (12), p.1271-1283

2024

Volltextzugriff (PDF)

Targeting TCTP as a New Therapeutic Strategy in Castration-resistant Prostate Cancer

Molecular therapy, 2012-12, Vol.20 (12), p.2244-2256

2012

Volltextzugriff (PDF)

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)

Oncotarget, 2018-01, Vol.9 (5), p.5517-5528

2018

Volltextzugriff (PDF)

TCTP regulates genotoxic stress and tumorigenicity via intercellular vesicular signaling

EMBO reports, 2024-04, Vol.25 (4), p.1962-1986

2024

Volltextzugriff (PDF)

The Functional Landscape of Hsp27 Reveals New Cellular Processes such as DNA Repair and Alternative Splicing and Proposes Novel Anticancer Targets

Molecular & cellular proteomics, 2014-12, Vol.13 (12), p.3585-3601

2014

Volltextzugriff (PDF)

Synthesis, Crystal Structure and Anti-Leukemic Activity of prop-2-en-1-one

MolBank, 2023-07, Vol.2023 (3)

2023

Volltextzugriff (PDF)

New 2,4-bis[phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex

Pharmaceuticals (Basel, Switzerland), 2023-12, Vol.17 (1)

2023

Volltextzugriff (PDF)

MYC Regulates the Anti-Tumor Immune Response through CD47 and PD-L1

Science (American Association for the Advancement of Science), 2016-03, Vol.352 (6282), p.227-231

2016

Volltextzugriff (PDF)

TCTP Has a Crucial Role in the Different Stages of Prostate Cancer Malignant Progression

TCTP/tpt1 - Remodeling Signaling from Stem Cell to Disease, 2017, Vol.64, p.255-261

2017

Volltextzugriff (PDF)

TP53INP1 as new therapeutic target in castration-resistant prostate cancer

The Prostate, 2012-09, Vol.72 (12), p.1286-1294

2012

Volltextzugriff (PDF)

TP53INPI As NewTherapeuticTarget in Castration-Resistant Prostate Cancer

The Prostate, 2012, Vol.72 (12), p.1286-1294

2012

Volltextzugriff (PDF)

Genetics and postsurgical neuropathic pain: An ancillary study of a multicentre survey

European journal of anaesthesiology, 2019-05, Vol.36 (5), p.342-350

2019

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)
Buchkapitel
(1)

Sprache

Englisch
(25)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(15)
Humans
(13)
Cancer
(10)
Animals
(9)
Gene Expression Regulation, Neoplastic
(7)
Male
(7)
Mice
(7)
Tumors
(7)
Cell Line, Tumor
(6)
Life Sciences
(6)
Neoplasms - Metabolism
(5)
Proteins
(5)
Apoptosis
(4)
Biomarkers, Tumor - Metabolism
(4)
Cancer Therapies
(4)
Immunotherapy
(4)
Oncology
(4)
Androgens
(3)
Antineoplastic Agents
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MYC regulates the antitumor immune response through CD47 and PD-L1

Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma

MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity

Hsp27 as a therapeutic target in cancers

Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments

Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs

New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex

Synthesis, Crystal Structure and Anti-Leukemic Activity of (E)-Pyrrolo[1,2-a]quinoxalin-4-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one

The MYC oncogene is a global regulator of the immune response

MYC: Master Regulator of Immune Privilege

TCTP as therapeutic target in cancers

Salmonella Typhimurium utilizes a T6SS-mediated antibacterial weapon to establish in the host gut

Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer

NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myeloma

Targeting TCTP as a New Therapeutic Strategy in Castration-resistant Prostate Cancer

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)

TCTP regulates genotoxic stress and tumorigenicity via intercellular vesicular signaling

The Functional Landscape of Hsp27 Reveals New Cellular Processes such as DNA Repair and Alternative Splicing and Proposes Novel Anticancer Targets

Synthesis, Crystal Structure and Anti-Leukemic Activity of prop-2-en-1-one

New 2,4-bis[phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex

MYC Regulates the Anti-Tumor Immune Response through CD47 and PD-L1

TCTP Has a Crucial Role in the Different Stages of Prostate Cancer Malignant Progression

TP53INP1 as new therapeutic target in castration-resistant prostate cancer

TP53INPI As NewTherapeuticTarget in Castration-Resistant Prostate Cancer

Genetics and postsurgical neuropathic pain: An ancillary study of a multicentre survey

Suchergebnisse filtern